BioLineRx Market Cap

BioLineRx has a market cap or net worth of 44.38 million as of December 19, 2025. Its market cap has decreased by -55.99% in one year.

Market Cap

44.38M

Enterprise Value

-1.42M

Revenue

42.17M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.70

Market Cap Chart

Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 44.38M, an increase of 27,125.18%. That is a compound annual growth rate of 34.61%.

Market Cap History

Date	Market Cap	% Change
Dec 21, 2025	44.38M	-48.12%
Dec 31, 2024	85.55M	-79.39%
Dec 31, 2023	415.08M	314.57%
Dec 29, 2022	100.12M	-67.59%
Dec 30, 2021	308.95M	60.58%
Dec 31, 2020	192.39M	108.80%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	111.55B
Danel (Adir Yeoshua)	2.75B
Kamada	1.35B
BrainsWay	1.04B
Bait Bakfar	1.03B
SofWave Medical	999.21M
Ilex Medical	737.86M
Novolog (Pharm-Up 1966)	649.32M

Market Cap Rankings